(Q36926935)

17 August 2017

Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease (English)

1 reference

autosomal dominant polycystic kidney disease

17 August 2017

1 reference

autosomal dominant polycystic kidney

inferred from title

1 reference

inferred from title

polycystic liver disease

1 reference

Fouad T Chebib

1

1 reference

17 August 2017

Yeonsoon Jung

2

1 reference

17 August 2017

Christina M Heyer

3

1 reference

17 August 2017

Maria V Irazabal

4

1 reference

17 August 2017

Marie C Hogan

5

1 reference

17 August 2017

Peter C Harris

6

1 reference

17 August 2017

Vicente E Torres

7

1 reference

17 August 2017

Ziad M El-Zoghby

8

1 reference

17 August 2017

language of work or name

English

0 references

publication date

29 February 2016

1 reference

Nephrology Dialysis Transplantation

17 August 2017

1 reference

17 August 2017

31

1 reference

17 August 2017

952-960

1 reference

17 August 2017

6

1 reference

Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Liver involvement in early autosomal-dominant polycystic kidney disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Whole-exome sequencing reveals LRP5 mutations and canonical Wnt signaling associated with hepatic cystogenesis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Type of PKD1 mutation influences renal outcome in ADPKD.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

A new equation to estimate glomerular filtration rate

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Polycystic disease of the liver

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Mutations in SEC63 cause autosomal dominant polycystic liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Hepatic cysts in autosomal dominant polycystic kidney disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Clinical profile of autosomal dominant polycystic liver disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Effects of dietary interventions on liver volume in humans

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4876970

Autosomal dominant polycystic kidney disease

4 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FNDT%2FGFW008

The Position of the Polycystic Kidney Disease 1 (PKD1) Gene Mutation Correlates with the Severity of Renal Disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FNDT%2FGFW008

Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort

21 January 2018

1 reference

12 December 2020

Autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Hepatic venous outflow obstruction in autosomal dominant polycystic kidney disease

1 reference

12 December 2020

Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease

1 reference

12 December 2020

Identifiers

DOI

10.1093/NDT/GFW008

1 reference

17 August 2017

1 reference

17 August 2017

1 reference